
Francis Medical
Cancer ablation by water vapor.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
* | $80.0m | Series C | |
Total Funding | 000k |
Related Content
Francis Medical is a pioneering medical device company that is developing innovative therapeutic solutions for the treatment of urological cancers, specifically prostate, kidney, and bladder cancer. The company operates in the healthcare sector, specifically the medical device and cancer treatment market.
Their business model revolves around the development and commercialization of a unique water vapor technology. This technology uses the thermal energy stored in water vapor to ablate, or destroy, cancerous tissue. Unlike traditional treatments, this minimally invasive procedure aims to protect surrounding structures, reducing the likelihood of common side effects such as urinary incontinence and erectile dysfunction.
Francis Medical's primary focus is on prostate cancer, the second most common cancer in American men. Their approach offers a more patient-friendly alternative to traditional treatments, which often involve surgery, hospital stays, and debilitating side effects. With Francis Medical's water vapor technology, patients can typically go home the same day and resume their normal lifestyle the next day.
The company's revenue model is likely based on the sale of their medical devices and the licensing of their proprietary technology to healthcare providers.
Francis Medical's work is not just business, it's personal. The company is named after Francis Hoey, the father of the founder, who died from prostate cancer after undergoing treatments with debilitating side effects. Today, the company's work stands as a tribute to Francis Hoey, aiming to provide more humane treatment options for cancer patients.
Keywords: Medical Device, Cancer Treatment, Prostate Cancer, Kidney Cancer, Bladder Cancer, Water Vapor Technology, Minimally Invasive, Urological Cancer, Healthcare Sector, Patient-Friendly Treatment.